Director Business Development - Early Cancer Detection

Director of Business Development - Early Cancer Detection About Natera Early Cancer Detection Early Cancer Detection is Natera’s newest focused business unit. Over the last several years, the team has rapidly developed an industry-leading technology platform, developed a robust product and launched a wide-scale FDA enabling clinical study which is currently enrolling patients. The next phase of the business will be a broad clinical launch. We are seeking a Director of Business Development to join our team and help expand our partnerships with study and supply partners; drive continued success with our clinical trials; and work with internal and external teams to enable clinical launch . This leader will be responsible for developing and executing agreements including, but not limited to, commercial partnerships; licensing, and potential acquisition evaluation and execution. POSITION SUMMARY: The Director of Business Development will evaluate external growth opportunities and represent Natera in negotiations with partners, customers, and suppliers. The person in this role is a natural leader with strategic vision, inspiring energy, and attention to detail. He/she will have deal-making experience from the life sciences industry, with superb analytic and modeling capabilities, creativity in deal structuring, a no-nonsense approach to negotiations, and a passion for delivering results. PRIMARY RESPONSIBILITIES: Partnership Development: Identify, evaluate, and execute strategic partnerships with suppliers, clinical study partners and other external parties as required. Deal Execution: Lead negotiations, structure agreements, and drive to closure in collaboration with Legal, Finance, and executive leadership. Market Development: Build a pipeline of opportunities by understanding evolving landscape and technologies in Early Cancer Detection. Cross-Functional Leadership: Work closely with RD, Product, and Clinical Affairs to align external opportunities with internal strategy and capabilities. QUALIFICATIONS:  Track record of leading and closing strategic collaboration and licensing agreements  8–10+ years of business development, strategic partnerships, or corporate development experience in biopharma, diagnostics, or life sciences necessary for the role  Demonstrated track record of structuring and closing deals in oncology, ideally in diagnostics.  Strong scientific and commercial understanding of oncology, immunology, or related therapeutic areas necessary for the role.  Exceptional relationship-building, negotiation, and communication skills.  Bachelor’s in healthcare, life sciences, pharmacy or related field is required; PhD in relevant field is a strong plus.  Industry background in diagnostics, software, life sciences, or private equity/venture capital. 3+ years’ experience in Corporate Business Development, investment banking or management consulting KNOWLEDGE, SKILLS, AND ABILITIES:  Strong communication and leadership skills necessary to effectively lead diligence teams and build credibility with the executive leadership of partners and collaborators  Strong analytical ability, comfort with science and numbers.  Strong attention to detail.  Passion for changing medicine and delivering results; curiosity to continue to learn about this rapidly evolving field  Demonstrated ability to manage client relationships Strong relationship development, communications and negotiations skills Why Join Us? This is a rare opportunity to drive the next Phase of Early Cancer Detection from the industry leader in Diagnostics. At Natera, you’ll join a fast-moving, high-impact team that is pushing the boundaries of what’s possible in healthcare innovation. OUR OPPORTUNITY Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of ca ... (truncated, view full listing at source)